Understanding the Orphan Drug Credit The Orphan Drug Credit, established under the Orphan Drug Act of 1983, is a federal tax incentive aimed at encouraging pharmaceutical companies to invest in research and development (R&D) for treatments of rare diseases that affect fewer than 200,000 individuals in the United States. The
Read more